Addex Therapeutics (ADXN) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.0 million.
- Addex Therapeutics' Profit After Tax fell 1182.67% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year increase of 9999.97%. This contributed to the annual value of $8.0 million for FY2024, which is 16823.63% up from last year.
- Addex Therapeutics' Profit After Tax amounted to -$2.0 million in Q3 2025, which was down 1182.67% from -$2.4 million recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Profit After Tax peaked at -$579883.9 during Q2 2023, and registered a low of -$3536.9 billion during Q1 2024.
- Over the past 4 years, Addex Therapeutics' median Profit After Tax value was -$2.6 million (recorded in 2023), while the average stood at -$235.8 billion.
- In the last 5 years, Addex Therapeutics' Profit After Tax tumbled by 13590096289.68% in 2024 and then skyrocketed by 10000.0% in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' Profit After Tax stood at -$21.6 million in 2022, then skyrocketed by 86.95% to -$2.8 million in 2023, then crashed by 98.83% to -$5.6 million in 2024, then surged by 64.82% to -$2.0 million in 2025.
- Its Profit After Tax stands at -$2.0 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$1.6 million for Q1 2025.